The use of intravenous lignocaine to reduce opioid consumption postoperatively and enhance recovery in posterior spine fusion surgeries
- Conditions
- Health Condition 1: M47- Spondylosis
- Registration Number
- CTRI/2023/06/053512
- Lead Sponsor
- Pondicherry Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Age 18-60 years of either sex.
2. Patients belonging to American society of Anesthesiologist physical status1 and 2.
3. Patients undergoing posterior spine fusion surgeries under General anaesthesia
1. Patients with allergy to local anaesthetic.
2. Patients undergoing spinal revision surgery .
3. Patients with bradycardia (HR < 50 bpm) and any rhythm abnormalities
4. Patients with seizure disorders.
5. Patients with uncontrolled diabetes, hypertension, chronic kidney disease, active coronary artery disease and severe COPD and Asthma.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the effect of intraoperative intravenous lignocaine infusion on postoperative opioid consumption during first 24 hrs after posterior spine fusion surgeries under general anaesthesia in 72 participants. <br/ ><br> <br/ ><br>OUTCOME VARIABLES: <br/ ><br>Postoperative opioid consumption <br/ ><br>Intraoperative opioid consumption <br/ ><br>VAS score in both the groups in first 24 hrs. <br/ ><br>Hemodynamic parameters (SBP, DBP & MAP) <br/ ><br>Quality of recovery using QOR â?? 15 scale <br/ ><br>Timepoint: 24 hrs
- Secondary Outcome Measures
Name Time Method 1.To compare the postoperative VAS score in first 24 hrs in both the groups . <br/ ><br>2.To compare the hemodynamic parameters (SBP, DBP & MAP) during the intraoperative period in both the groups. <br/ ><br>3.To determine the quality of recovery using QOR â?? 15 scale after 24 hrs of surgery in both the groups. <br/ ><br>Timepoint: 24 hrs